Astrotech (NASDAQ:ASTC) Cut to “Strong Sell” at Wall Street Zen

Wall Street Zen downgraded shares of Astrotech (NASDAQ:ASTC) from a sell rating to a strong sell rating in a report published on Monday morning.

Separately, Weiss Ratings upgraded Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, May 27th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Astrotech currently has an average rating of “Sell”.

Astrotech Trading Down 3.3%

Shares of NASDAQ ASTC opened at $7.30 on Monday. The firm has a market capitalization of $13.14 million, a P/E ratio of -0.87 and a beta of 4.77. The firm’s 50-day moving average price is $14.52 and its 200-day moving average price is $7.15. Astrotech has a 1-year low of $1.91 and a 1-year high of $68.85.

Astrotech (NASDAQ:ASTC) last issued its earnings results on Wednesday, May 13th. The aerospace company reported ($2.25) EPS for the quarter. Astrotech had a negative net margin of 1,397.82% and a negative return on equity of 81.85%. The firm had revenue of $0.34 million during the quarter.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Susquehanna International Group LLP acquired a new position in shares of Astrotech during the third quarter valued at about $66,000. DRW Securities LLC increased its position in shares of Astrotech by 168.5% during the fourth quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock worth $109,000 after acquiring an additional 19,747 shares in the last quarter. Finally, J. Safra Sarasin Holding AG acquired a new stake in shares of Astrotech in the 1st quarter worth about $140,000. Institutional investors and hedge funds own 24.35% of the company’s stock.

About Astrotech

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.